Polyfluoroalkyl chemicals and menopause among women 20-65 years of age (NHANES)

Environmental Health Perspectives

Volumn 122, Issue 2, 2014, Pages 145-150

  Taylor, Kyla W ^a   Hoffman, Kate ^b   Thayer, Kristina A ^a   Daniels, Julie L ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANOFLUORINE DERIVATIVE; PERFLUOROHEXANE SULFONATE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; POLYFLUOROALKYL CHEMICAL; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DOSE RESPONSE; FEMALE; HAZARD RATIO; HUMAN; HYSTERECTOMY; LIMIT OF DETECTION; MENOPAUSE; MENSTRUATION; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCTIVE HEALTH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STATISTICAL ANALYSIS; TANDEM MASS SPECTROMETRY;

ADULT; AGE FACTORS; ALKANESULFONIC ACIDS; CAPRYLATES; ENVIRONMENTAL EXPOSURE; FEMALE; FLUOROCARBONS; HUMANS; MENOPAUSE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; UNITED STATES;

EID: 84893419514     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1306707     Document Type: Article

References (43)

1. Akahoshi M. 2002. The effects of body mass index on age at menopause. Int J Obes Relat Metab Disord 26:961-968.
2. Andersen ME, Butenhoff JL, Chang SC, Farrar DG, Kennedy GL Jr, Lau C, et al. 2008. Perfluoroalkyl acids and related chemistries-toxicokinetics and modes of action. Toxicol Sci 102:3-14.
3. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. 2006. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 13:265-279.
4. Bartell SC, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland, K. 2010. Rate of decline in serum PFOA concentrations after granular activiated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 118:222-228; doi:10.1289/ehp.0901252.
5. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL. 2007a. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES). Environ Sci Technol 41:2237-2242.
6. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. 2007b. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115:1596-1602; doi:10.1289/ehp.10598.
7. Calafat AM, Ye X, Silva MJ, Kuklenyik Z, Needham LL. 2006. Human exposure assessment to environmental chemicals using biomonitoring. Int J Androl 29:166-171.
8. CDC (Centers for Disease Control and Prevention). 2009. Fourth National Report on Human Exposure to Environmental Chemicals. Available: http://www.Cdc.Gov/exposurereport/index.Html [accessed 31 December 2013].
9. CDC (Centers for Disease Control and Prevention). 2012. National Health and Nutrition Examination Survey. Available: http://www.cdc.gov/nchs/nhanes.htm [accessed 15 September 2012].
10. CDC (Centers for Disease Control and Prevention). 2013a. National Health and Nutrition Examination Survey: Analytic Guidelines, 1999-2010. Vital Health Stat 2(161). Available: http://www.cdc.gov/nchs/data/series/sr_02/sr02_161.pdf [accessed 3 January 2014].
11. CDC (Centers for Disease Control and Prevention). 2013b. Questionnaires, Datasets, and Related Documentation. Available: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm [accessed 30 December 2013].
12. Chan E, Burstyn I, Cherry N, Bamforth F, Martin JW. 2011. Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res 111:559-564.
13. Cooper GS, Savitz DA, Millikan R, Chiu Kit T. 2002. Organochlorine exposure and age at natural menopause. Epidemiology 13:729-733.
14. Dallaire R, Dewailly É, Pereg D, Dery S, Ayotte P. 2009. Thyroid function and plasma concentrations of polyhalogenated compounds in inuit adults. Environ Health Perspect 117:1380-1386; doi:10.1289/ ehp.0900633.
15. Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, et al. 2006. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med 48:771-779.
16. Frisbee SJ, Brooks AP Jr, Maher A, Flensborg P, Arnold S, Fletcher T, et al. 2009. The C8 Health Project: design, methods, and participants. Environ Health Perspect 117:1873-1882; doi:10.1289/ehp.0800379.
17. Fromme H, Schlummer M, Möller A, Gruber L, Wolz G, Ungewiss J, et al. 2007. Exposure of an adult population to perfluorinated substances using duplicate diet portions and biomonitoring data. Environ Sci Technol 41:7928-7933.
18. Graubard BI, Korn EL. 1999. Analyzing health surveys for cancer-related objectives. J Natl Cancer Inst 91:1005-1016.
19. Greenland S, Robins JM. 1986. Identifiability, exchangeability, and epidemiological confounding. Int J Epidemiol 15:413-419.
20. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, et al. 2004. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112:1204-1207; doi:10.1289/ehp.6864.
21. Jensen AA, Leffers H. 2008. Emerging endocrine disrupters: perfluoroalkylated substances. Int J Androl 31:161-169.
22. Ji K, Kim S, Kho Y, Paek D, Sakong J, Ha J, et al. 2012. Serum concentrations of major perfluorinated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones. Environ Int 45:78-85.
23. Jones PD, Hu W, De Coen W, Newsted JL, Giesy JP. 2003. Binding of perfluorinated fatty acids to serum proteins. Environ Toxicol Chem 22:2639-2649.
24. Kato K, Calafat AM, Wong LY, Wanigatunga AA, Caudill SP, Needham LL. 2009. Polyfluoroalkyl compounds in pooled sera from children participating in the national health and nutrition examination survey 2001-2002. Environ Sci Technol 43:2641-2647.
25. Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. 2011. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999-2008. Environ Sci Technol 45:8037-8045.
26. Knox SS, Jackson T, Javins B, Frisbee SJ, Shankar A, Ducatman AM. 2011. Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab 96:1747-1753.
27. Korn EL, Graubard BI. 1991. Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 81:1166-1173.
28. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366-394.
29. Lin CY, Wen LL, Lin LY, Wen TW, Lien GW, Hsu SH, et al. 2013. The associations between serum perfluorinated chemicals and thyroid function in adolescents and young adults. J Hazard Mater 244-245:637-644.
30. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. 2009. Age at natural menopause and risk of ischemic stroke: the Framingham Heart Study. Stroke 40:1044-1049.
31. Lopez-Espinosa MJ, Fletcher T, Armstrong B, Genser B, Dhatariya K, Mondal D, et al. 2011. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol 45:8160-8166.
32. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS. 2010. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect 118:686-692; doi:10.1289/ehp.0901584.
33. Nelson JW, Hatch EE, Webster TF. 2010. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 118:197-202; doi:10.1289/ehp.0901165.
34. Olsen GW, Burris JM, Burlew MM, Mandel JH. 2003. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45:260-270.
35. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1305; doi:10.1289/ehp.10009.
36. Olsen GW, Zobel LR. 2007. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 81:231-246.
37. Organisation for Economic Co-operation and Development. 2002. Co-operation on Existing Chemicals: Hazard Assessment of Perfluorooctane Sulfonate and Its Salts. ENV/JM/RD(2002)17/FINAL. Available: http://www.oecd.org/chemicalsafety/risk-assessment/2382880.pdf [accessed 19 December 2013].
38. Pearce N, Pearce N, Checkoway H, Kriebel D. 2007. Bias in occupational epidemiology studies. Occup Environ Med 64:562-568.
39. Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V. 2009. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol 170:1268-1278.
40. U.S. EPA (U.S. Environmental Protection Agency). 2012. Long-Chain Perfluorinated Chemicals (PFCS) Action Plan Summary. Available: http://www.epa.gov/oppt/existingchemicals/pubs/actionplans/pfcs.html [accessed 12 November 2012].
41. Wellons M, Ouyang P, Schreiner PJ, Herrington DM, Vaidya D. 2012. Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis. Menopause 19:1081-1087.
42. Weng HY, Hsueh YH, Messam LL, Hertz-Picciotto I. 2009. Methods of covariate selection: directed acyclic graphs and the change-in-estimate procedure. Am J Epidemiol 169:1182-1190.
43. Zhao Y, Tan YS, Haslam SZ, Yang C. 2010. Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice. Toxicol Sci 115:214-224.